Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019.

Sosa LE, Njie GJ, Lobato MN, Bamrah Morris S, Buchta W, Casey ML, Goswami ND, Gruden M, Hurst BJ, Khan AR, Kuhar DT, Lewinsohn DM, Mathew TA, Mazurek GH, Reves R, Paulos L, Thanassi W, Will L, Belknap R.

MMWR Morb Mortal Wkly Rep. 2019 May 17;68(19):439-443. doi: 10.15585/mmwr.mm6819a3.

2.

Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis.

Badal-Faesen S, Firnhaber C, Kendall MA, Wu X, Grinsztejn B, Escada RODS, Fernandez M, Hogg E, Sanne I, Johnson P, Alland D, Mazurek GH, Benator DA, Luetkemeyer AF; AIDS Clinical Trials Group A5295; Tuberculosis Trials Consortium Study 34 Teams.

J Clin Med. 2017 Aug 7;6(8). pii: E78. doi: 10.3390/jcm6080078.

3.

Assessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits.

Lempp JM, Zajdowicz MJ, Hankinson AL, Toney SR, Keep LW, Mancuso JD, Mazurek GH.

PLoS One. 2017 May 17;12(5):e0177752. doi: 10.1371/journal.pone.0177752. eCollection 2017.

4.

Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis.

Scott C, Cavanaugh JS, Silk BJ, Ershova J, Mazurek GH, LoBue PA, Moonan PK.

Emerg Infect Dis. 2017 Mar;23(3):456-462. doi: 10.3201/eid2303.161916.

5.

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL.

Clin Infect Dis. 2017 Jan 15;64(2):111-115. doi: 10.1093/cid/ciw778.

6.

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL.

Clin Infect Dis. 2017 Jan 15;64(2):e1-e33. doi: 10.1093/cid/ciw694. Epub 2016 Dec 8.

PMID:
27932390
7.

Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.

Luetkemeyer AF, Firnhaber C, Kendall MA, Wu X, Mazurek GH, Benator DA, Arduino R, Fernandez M, Guy E, Johnson P, Metchock B, Sattler F, Telzak E, Wang YF, Weiner M, Swindells S, Sanne IM, Havlir DV, Grinsztejn B, Alland D; AIDS Clinical Trials Group A5295 and Tuberculosis Trials Consortium Study 34 Teams.

Clin Infect Dis. 2016 May 1;62(9):1081-8. doi: 10.1093/cid/ciw035. Epub 2016 Feb 2.

8.

Tuberculin Skin Tests versus Interferon-Gamma Release Assays in Tuberculosis Screening among Immigrant Visa Applicants.

Chuke SO, Yen NT, Laserson KF, Phuoc NH, Trinh NA, Nhung DT, Mai VT, Qui AD, Hai HH, Loan le TH, Jones WG, Whitworth WC, Shah JJ, Painter JA, Mazurek GH, Maloney SA.

Tuberc Res Treat. 2014;2014:217969. doi: 10.1155/2014/217969. Epub 2014 Mar 6.

9.

Automation of an interferon-γ release assay and comparison to the tuberculin skin test for screening basic military trainees for Mycobacterium tuberculosis infection.

Goodwin DJ, Mazurek GH, Campbell BH, Bohanon J, West KB, Bell JJ, Powell R, Toney S, Morris JA, Yamane GK, Sjoberg PA.

Mil Med. 2014 Mar;179(3):333-41. doi: 10.7205/MILMED-D-13-00364.

PMID:
24594471
10.

Variability of the QuantiFERON®-TB gold in-tube test using automated and manual methods.

Whitworth WC, Goodwin DJ, Racster L, West KB, Chuke SO, Daniels LJ, Campbell BH, Bohanon J, Jaffar AT, Drane W, Sjoberg PA, Mazurek GH.

PLoS One. 2014 Jan 23;9(1):e86721. doi: 10.1371/journal.pone.0086721. eCollection 2014.

11.

The elusive "gold" standard for detecting Mycobacterium tuberculosis infection.

Mancuso JD, Bernardo J, Mazurek GH.

Am J Respir Crit Care Med. 2013 Jan 15;187(2):122-4. doi: 10.1164/rccm.201211-2033ED. No abstract available.

PMID:
23322793
12.

Within-subject interlaboratory variability of QuantiFERON-TB gold in-tube tests.

Whitworth WC, Hamilton LR, Goodwin DJ, Barrera C, West KB, Racster L, Daniels LJ, Chuke SO, Campbell BH, Bohanon J, Jaffar AT, Drane W, Maserang D, Mazurek GH.

PLoS One. 2012;7(9):e43790. doi: 10.1371/journal.pone.0043790. Epub 2012 Sep 6.

13.

Discordance among commercially available diagnostics for latent tuberculosis infection.

Mancuso JD, Mazurek GH, Tribble D, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW.

Am J Respir Crit Care Med. 2012 Feb 15;185(4):427-34. doi: 10.1164/rccm.201107-1244OC. Epub 2011 Dec 8.

14.

Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens.

Kellar KL, Gehrke J, Weis SE, Mahmutovic-Mayhew A, Davila B, Zajdowicz MJ, Scarborough R, LoBue PA, Lardizabal AA, Daley CL, Reves RR, Bernardo J, Campbell BH, Whitworth WC, Mazurek GH.

PLoS One. 2011;6(11):e26545. doi: 10.1371/journal.pone.0026545. Epub 2011 Nov 21.

15.

Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics.

Mancuso JD, Tribble D, Mazurek GH, Li Y, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW.

Clin Infect Dis. 2011 Aug 1;53(3):234-44. doi: 10.1093/cid/cir321.

16.

Predictors of discordant tuberculin skin test and QuantiFERON®-TB Gold In-Tube results in various high-risk groups.

Weinfurter P, Blumberg HM, Goldbaum G, Royce R, Pang J, Tapia J, Bethel J, Mazurek GH, Toney S, Albalak R; Tuberculosis Epidemiological Studies Consortium.

Int J Tuberc Lung Dis. 2011 Aug;15(8):1056-61. doi: 10.5588/ijtld.10.0650.

PMID:
21740668
17.

Unusual interferon gamma measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube tests.

Powell RD 3rd, Whitworth WC, Bernardo J, Moonan PK, Mazurek GH.

PLoS One. 2011;6(6):e20061. doi: 10.1371/journal.pone.0020061. Epub 2011 Jun 8.

18.

Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Jun 25;59(RR-5):1-25.

19.

Prospective comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube assay for the detection of latent tuberculosis infection among healthcare workers in a low-incidence setting.

Cummings KJ, Smith TS, Shogren ES, Khakoo R, Nanda S, Bunner L, Smithmyer A, Soccorsi D, Kashon ML, Mazurek GH, Friedman LN, Weissman DN.

Infect Control Hosp Epidemiol. 2009 Nov;30(11):1123-6. doi: 10.1086/644754.

PMID:
19803719
20.

Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients.

Winthrop KL, Nyendak M, Calvet H, Oh P, Lo M, Swarbrick G, Johnson C, Lewinsohn DA, Lewinsohn DM, Mazurek GH.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1357-63. doi: 10.2215/CJN.01010208. Epub 2008 Jun 11.

21.

Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.

Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, Reves RR, Toney SR, Daniels LJ, LoBue PA.

Clin Infect Dis. 2007 Oct 1;45(7):837-45. Epub 2007 Aug 24.

PMID:
17806047
22.

Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays.

Mazurek GH, Zajdowicz MJ, Hankinson AL, Costigan DJ, Toney SR, Rothel JS, Daniels LJ, Pascual FB, Shang N, Keep LW, LoBue PA.

Clin Infect Dis. 2007 Oct 1;45(7):826-36. Epub 2007 Aug 24.

PMID:
17806046
23.

Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.

Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A; Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2005 Dec 16;54(RR-15):49-55. Erratum in: MMWR Morb Mortal Wkly Rep. 2005 Dec 23;54(50):1288.

24.

Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing.

Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley CL, Granich RM, Mazurek GH, Reingold AL, Riley LW, Colford JM Jr.

JAMA. 2005 Jun 8;293(22):2746-55.

PMID:
15941804
25.

Proteomic profiling of intact mycobacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Hettick JM, Kashon ML, Simpson JP, Siegel PD, Mazurek GH, Weissman DN.

Anal Chem. 2004 Oct 1;76(19):5769-76.

PMID:
15456297
26.

Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens.

Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I.

Am J Respir Crit Care Med. 2004 Jul 1;170(1):59-64. Epub 2004 Apr 1.

PMID:
15059788
27.

Detection of Mycobacterium tuberculosis infection by whole-blood interferon-gamma release assay.

Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Iademarco MF.

Clin Infect Dis. 2003 May 1;36(9):1207-8; author reply 1209-10. No abstract available.

PMID:
12715323
29.

Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection.

Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, Iademarco MF, Rothel JS.

JAMA. 2001 Oct 10;286(14):1740-7.

PMID:
11594899
30.

Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.

Hannan MM, Desmond EP, Morlock GP, Mazurek GH, Crawford JT.

J Clin Microbiol. 2001 Feb;39(2):647-50.

31.

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

Morlock GP, Crawford JT, Butler WR, Brim SE, Sikes D, Mazurek GH, Woodley CL, Cooksey RC.

Antimicrob Agents Chemother. 2000 Sep;44(9):2291-5.

32.
33.

Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry.

Moore AV, Kirk SM, Callister SM, Mazurek GH, Schell RF.

J Clin Microbiol. 1999 Mar;37(3):479-83.

34.

Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours.

Kirk SM, Schell RF, Moore AV, Callister SM, Mazurek GH.

J Clin Microbiol. 1998 Jun;36(6):1568-73.

35.

Genetic similarity among Mycobacterium avium isolates from blood, stool, and sputum of persons with AIDS.

Mazurek GH, Chin DP, Hartman S, Reddy V, Horsburgh CR Jr, Green TA, Yajko DM, Hopewell PC, Reingold AL, Crawford JT.

J Infect Dis. 1997 Oct;176(4):976-83.

PMID:
9333156
36.

Tuberculosis outbreak in a Texas prison, 1994.

Bergmire-Sweat D, Barnett BJ, Harris SL, Taylor JP, Mazurek GH, Reddy V.

Epidemiol Infect. 1996 Dec;117(3):485-92.

37.

DNA fingerprinting by infrequent-restriction-site amplification.

Mazurek GH, Reddy V, Marston BJ, Haas WH, Crawford JT.

J Clin Microbiol. 1996 Oct;34(10):2386-90.

38.

Detection of Mycobacterium tuberculosis in cerebrospinal fluid following immunomagnetic enrichment.

Mazurek GH, Reddy V, Murphy D, Ansari T.

J Clin Microbiol. 1996 Feb;34(2):450-3.

39.

Tuberculosis outbreak among healthcare workers in a community hospital.

Griffith DE, Hardeman JL, Zhang Y, Wallace RJ, Mazurek GH.

Am J Respir Crit Care Med. 1995 Aug;152(2):808-11.

PMID:
7633747
40.

Genetic differences between BCG substrains.

Zhang Y, Wallace RJ Jr, Mazurek GH.

Tuber Lung Dis. 1995 Feb;76(1):43-50.

PMID:
7718847
41.

DNA fingerprinting of pathogenic bacteria by fluorophore-enhanced repetitive sequence-based polymerase chain reaction.

Versalovic J, Kapur V, Koeuth T, Mazurek GH, Whittam TS, Musser JM, Lupski JR.

Arch Pathol Lab Med. 1995 Jan;119(1):23-9.

PMID:
7802548
42.

Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease.

Wallace RJ Jr, Brown BA, Griffith DE, Girard WM, Murphy DT, Onyi GO, Steingrube VA, Mazurek GH.

Am J Respir Crit Care Med. 1994 May;149(5):1335-41.

PMID:
8173775
43.

DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus.

Wallace RJ Jr, Zhang Y, Brown BA, Fraser V, Mazurek GH, Maloney S.

J Clin Microbiol. 1993 Oct;31(10):2697-701.

44.

Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool.

Mazurek GH, Hartman S, Zhang Y, Brown BA, Hector JS, Murphy D, Wallace RJ Jr.

J Clin Microbiol. 1993 Feb;31(2):390-4.

45.

DNA polymorphisms in strains of Mycobacterium tuberculosis analyzed by pulsed-field gel electrophoresis: a tool for epidemiology.

Zhang Y, Mazurek GH, Cave MD, Eisenach KD, Pang Y, Murphy DT, Wallace RJ Jr.

J Clin Microbiol. 1992 Jun;30(6):1551-6.

46.
47.

Chromosomal DNA fingerprint patterns produced with IS6110 as strain-specific markers for epidemiologic study of tuberculosis.

Mazurek GH, Cave MD, Eisenach KD, Wallace RJ Jr, Bates JH, Crawford JT.

J Clin Microbiol. 1991 Sep;29(9):2030-3.

48.

Pneumonia in chronic obstructive lung disease.

Griffith DE, Mazurek GH.

Infect Dis Clin North Am. 1991 Sep;5(3):467-84. Review.

PMID:
1955695

Supplemental Content

Loading ...
Support Center